Close

Roth Capital Affirms Stemline Therapeutics (STML) at 'Buy'; Strong Cash Position Noted Ahead of ASH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. SNAP
9. TMUS
10. BSX


Go back to Roth Capital Affirms Stemline Therapeutics (STML) at 'Buy'; Strong Cash Position Noted Ahead of ASH
STEMLINE THRPTS (NASDAQ: STML) Delayed: 11.83 --0 (-0%)
Previous Close $11.83    52 Week High $14.20 
Open $1.49    52 Week Low $3.88 
Day High $11.83    P/E N/A 
Day Low $11.83    EPS $-2.35 
Volume 200,254